Fantastic to see @durham_uni #NorthernAccelerator spin-out @spherauk recognised as one of the UK's leading companies tackling the climate crisis #northeastinnovation #researchcommercialisation @northeastlep @ResEngland @NCUBtweetsRead More
Happy birthday @MagnitudeBio - so much progress and growth so far, and much more to come!Read More
Another great job opportunity with @UniofNewcastle #NorthernAccelerator spin-out @AtelerixLtd based at @BiosphereNCLRead More
Fantastic news for the region's innovation ecosystem as NETPark gets approval for £50m expansion #Northeastinnovation #fromlabtolifeRead More
RT @bionowevents: #BioCap2021 2 Weeks to go! Looking to invest in innovative life science companies? Seeking investment for your business?…Read More
RT @northeastlep: One of our favourite events of the year! The #InnovationFestival21 will be another fantastic week of innovation, ideas an…Read More
Fantastic new business space from @durham_uni at @NETParkUK #northeastinnovation #researchcommercialisation #fromlabtolifeRead More
RT @OrbitDurham: Come along to hear our Centre Manager (Will Bevan-Nicholls) give an update on our Launch. 🚀Read More
RT @bionowevents: Join @Bionow at this years' #BioCap2021 Conference and discover the experiences of some of the UK’s most innovative comp…Read More
RT @Bionow: Looking for investment? BioCap (30th Sept) gives you the opportunity to network with investors & ALSO to pitch to them - the cl…Read More
To date we have
Awarded to pre-incorporation projects
Invested from our Seed Investment Fund
Investments from our Seed Investment Fund
Academics trained in impact & entrepreneurship
Atelerix was the first Northern Accelerator spin-out, with CEO Dr Mick McLean recruited through the project’s ‘Execs into Business’ programme.
This Durham University spin-out is helping companies discover and develop new age-related treatments faster.
Healthcare experts and collaborators at Sunderland have been awarded funding of almost £50,000 from Northern Accelerator to develop a drug for the pre-clinical proof-of-concept stage over the next eight months
This innovative device could revolutionise the way we diagnose diseases, such as the newly emerged strain of coronavirus, COVID-19.
gliff.ai is an innovative artificial intelligence (AI) company with ambitious plans to treble their staff headcount, expand into international export markets and secure multi-million-pound investment over the coming year.
Professor Kataky’s innovative work with biofilms to control the formation and spread of bacteria will make a real-world impact in the form of smart bandage technology. This can reduce reliance on antibiotics and improve patient outcomes, by reducing the risk of disease and infection when treating wounds.
Professor Che Connon is a serial academic entrepreneur, spinning out three companies from Newcastle University and bridging the gap between academia and private enterprise.
Growing up in North-Eastern Italy, Martina had a passion for STEM from a very young age.